122 related articles for article (PubMed ID: 14741282)
1. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.
Chu T; Li R; Hu S; Liu X; Wang X
Nucl Med Biol; 2004 Feb; 31(2):199-203. PubMed ID: 15013485
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biological evaluation of ⁹⁹mTc-N4IPA for single photon emission computerized tomography imaging of hypoxia in mouse tumor.
Li N; Zhu H; Chu TW; Yang Z
Eur J Med Chem; 2013 Nov; 69():223-31. PubMed ID: 24042045
[TBL] [Abstract][Full Text] [Related]
5.
Lin X; Ruan Q; Zhang X; Duan X; Teng Y; Zhang J
Appl Radiat Isot; 2018 Oct; 140():289-293. PubMed ID: 30092554
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro and in vivo evaluation of three radioiodinated nitroimidazole analogues as tumor hypoxia markers.
Li Z; Chu T; Liu X; Wang X
Nucl Med Biol; 2005 Apr; 32(3):225-31. PubMed ID: 15820757
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia.
Mallia MB; Subramanian S; Banerjee S; Sarma HD; Venkatesh M
Bioorg Med Chem; 2006 Dec; 14(23):7666-70. PubMed ID: 16949291
[TBL] [Abstract][Full Text] [Related]
8. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
9. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
Giglio J; Fernández S; Pietzsch HJ; Dematteis S; Moreno M; Pacheco JP; Cerecetto H; Rey A
Nucl Med Biol; 2012 Jul; 39(5):679-86. PubMed ID: 22534030
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
Zhang Q; Zhang Q; Guan Y; Liu S; Chen Q; Li X
Med Sci Monit; 2016 Oct; 22():3778-3791. PubMed ID: 27752036
[TBL] [Abstract][Full Text] [Related]
12. Improving tumor/muscle and tumor/blood ratios of
Li S; Chu T
Bioorg Med Chem Lett; 2023 Feb; 82():129154. PubMed ID: 36736496
[TBL] [Abstract][Full Text] [Related]
13. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
14. BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.
Melo T; Duncan J; Ballinger JR; Rauth AM
J Nucl Med; 2000 Jan; 41(1):169-76. PubMed ID: 10647620
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
16. A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart.
Rumsey WL; Cyr JE; Raju N; Narra RK
Biochem Biophys Res Commun; 1993 Jun; 193(3):1239-46. PubMed ID: 8323545
[TBL] [Abstract][Full Text] [Related]
17. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
18. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Venkatesh M; Banerjee S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5233-7. PubMed ID: 18774708
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a novel (99m)Tc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia.
Joyard Y; Le Joncour V; Castel H; Diouf CB; Bischoff L; Papamicaël C; Levacher V; Vera P; Bohn P
Bioorg Med Chem Lett; 2013 Jul; 23(13):3704-8. PubMed ID: 23726027
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]